potential chemo-free therapy in triple-positive mbc with ribociclib
Published 1 month ago • 37 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
2:27
monarch: chemo-free options for triple-positive metastatic breast cancer
-
2:03
detect v: second interim analysis of chemotherapy-free strategies in her2-, hr mbc
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
2:46
right choice: ribociclib et vs combo chemo in aggressive hr /her2− advanced breast cancer
-
2:24
current and future her2 , hr- metastatic breast cancer treatment approaches
-
1:26
ribecca: ribociclib, a cdk4/6 inhibitor in er breast cancer
-
5:12
monaleesa-3: ribociclib plus fulvestrant in hr mbc
-
0:59
ribociclib in adjuvant hr breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
1:55
advances in treatments for her2-positive metastatic breast cancer
-
4:45
trastuzumab plus chemotherapy or endocrine therapy for triple-positive breast cancer
-
1:29
poziotinib for her2-positive metastatic breast cancer
-
1:29
monaleesa-2: ribociclib letrozole in pts with de novo metastatic disease and late recurrence
-
1:39
frontline endocrine therapies and ribociclib in early stage hr her2- breast cancer
-
51:38
medical update: her2-positive and triple-positive metastatic breast cancer
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
0:48
maintain: fulvestrant or exemestane /- ribociclib after anti-estrogen therapy cdk4/6i in hr mbc
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
8:55
researcher comment: ribociclib efficacy for visceral metastases | denise yardley